Position in GERN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$26,112
-$4,284 QoQ
Shares Held
20,400
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#185
of 258 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LCM Capital Management Inc holds $1,381,075 across 6 Biotechnology names. GERN ranks #6 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,196 | $594,089 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
603 | $375,994 | |
| 3 | INCY |
Incyte Corp
|
2,158 | $244,630 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
15,000 | $85,200 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
15,000 | $55,050 | |
| 6 | GERN |
Geron Corp
This page
|
20,400 | $26,112 |
All Filings in GERN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,112 | 20,400 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $30,396 | 20,400 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $29,568 | 22,400 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $16,988 | 12,400 | Shares | Sole | 2025-10-28 | |
| No filing history on record for this holder in this stock. | ||||||